TSHR and thyroid gland carcinoma: TSHR-based therapeutic approaches, including small-molecule drugs, nanomaterials, and advanced immunotherapies, represent new avenues for treating thyroid cancer, particularly in patients who have developed resistance to traditional treatments, such as radioiodine therapy (Fig. 2).